Inhibition of eukaryotic translation by nucleoside 5'-monophosphate analogs of mRNA 5'-cap: changes in N7 substituent affect analog activity-Reference-Cited by-同舟云学术

Inhibition of eukaryotic translation by nucleoside 5'-monophosphate analogs of mRNA 5'-cap: changes in N7 substituent affect analog activity

Published:1989-05-30 Issue:11 Volume:28 Page:4771-4778
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Darzynkiewicz Edward,Stepinski Janusz,Ekiel Irena,Goyer Charles,Sonenberg Nahum,Temeriusz Andrzej,Jin Youxin,Sijuwade Teju,Haber Dorota,Tahara Stanley M.

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi00437a038

Reference38 articles.

1. The effect of “cap” analogs on reovirus mRNA binding to wheat germ ribosomes. Evidence for enhancement of ribosomal binding via a preferred cap conformation.

2. Site-directed mutagenesis of the tryptophan residues in yeast eukaryotic initiation factor 4E. Effects on cap binding activity.

3. 5'-terminal cap structure in eucaryotic messenger ribonucleic acids

4. Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end.

5. Methyl esterification of m7G5′p reversibly blocks its activity as an analog of eukaryotic mRNA 5′-caps

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Visible Light Activates Coumarin‐Caged mRNA for Cytoplasmic Cap Methylation in Cells;Chemistry – A European Journal;2023-11-13

2. Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer;Journal of Medicinal Chemistry;2023-07-20

3. Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer;2023-05-24

4. The legacy of mRNA engineering: A lineup of pioneers for the Nobel Prize;Molecular Therapy - Nucleic Acids;2022-09

5. The mTOR/4E-BP1/eIF4E Signalling Pathway as a Source of Cancer Drug Targets;Current Medicinal Chemistry;2022-06